Chris Cisar

Chris Cisar is an accomplished executive in the healthcare industry with a diverse background in market access, health economics, and managed care. Currently serving as Vice President of Market Access and Health Economics at DELFI Diagnostics since 2022, Cisar previously held the position of Vice President, Managed Care at Veracyte, Inc. from 2021 to 2022. Notable prior roles include Executive Director of National Accounts at Myriad Genetics from 2012 to 2020, and various leadership positions at Pfizer from 1998 to 2012, where responsibilities included strategic accounts, sales operations, and regional management. Cisar also provided consulting services to the healthcare sector with i-Predict, LLC in 2012, focusing on optimizing business performance through information technology and process improvements. Cisar earned a BS in Business Logistics from Penn State University and has enhanced leadership skills through additional education at the Center for Creative Leadership and Villanova University.